These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 28849584)
1. 5-Fluorouracil treatment alters the expression of intestinal transporters in rats. Yotsumoto K; Akiyoshi T; Wada N; Imaoka A; Ohtani H Biopharm Drug Dispos; 2017 Dec; 38(9):509-516. PubMed ID: 28849584 [TBL] [Abstract][Full Text] [Related]
2. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib. Graber-Maier A; Gutmann H; Drewe J Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289 [TBL] [Abstract][Full Text] [Related]
3. Role of intestinal efflux transporters in the intestinal absorption of methotrexate in rats. Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M J Pharm Pharmacol; 2007 Sep; 59(9):1263-70. PubMed ID: 17883898 [TBL] [Abstract][Full Text] [Related]
4. Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats. MacLean C; Moenning U; Reichel A; Fricker G Drug Metab Dispos; 2008 Jul; 36(7):1249-54. PubMed ID: 18378562 [TBL] [Abstract][Full Text] [Related]
5. Irinotecan-induced gastrointestinal damage alters the expression of peptide transporter 1 and absorption of cephalexin in rats. Imaoka A; Hattori T; Akiyoshi T; Ohtani H Biopharm Drug Dispos; 2023 Oct; 44(5):372-379. PubMed ID: 37507848 [TBL] [Abstract][Full Text] [Related]
6. Improvement of the oral drug absorption of topotecan through the inhibition of intestinal xenobiotic efflux transporter, breast cancer resistance protein, by excipients. Yamagata T; Kusuhara H; Morishita M; Takayama K; Benameur H; Sugiyama Y Drug Metab Dispos; 2007 Jul; 35(7):1142-8. PubMed ID: 17446265 [TBL] [Abstract][Full Text] [Related]
7. Characterization of efflux transporters involved in distribution and disposition of apixaban. Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of intestinal absorption of amtolmetin guacyl in rats: breast cancer resistant protein as a primary barrier of oral bioavailability. Rong Z; Xu Y; Zhang C; Xiang D; Li X; Liu D Life Sci; 2013 Feb; 92(3):245-51. PubMed ID: 23333829 [TBL] [Abstract][Full Text] [Related]
9. In vivo assessment of the impact of efflux transporter on oral drug absorption using portal vein-cannulated rats. Matsuda Y; Konno Y; Hashimoto T; Nagai M; Taguchi T; Satsukawa M; Yamashita S Drug Metab Dispos; 2013 Aug; 41(8):1514-21. PubMed ID: 23686319 [TBL] [Abstract][Full Text] [Related]
10. Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation. Yousif S; Chaves C; Potin S; Margaill I; Scherrmann JM; Declèves X J Neurochem; 2012 Nov; 123(4):491-503. PubMed ID: 22845665 [TBL] [Abstract][Full Text] [Related]
11. Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma. Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157 [TBL] [Abstract][Full Text] [Related]
12. Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood-brain barrier. Nagasaka Y; Oda K; Iwatsubo T; Kawamura A; Usui T Biopharm Drug Dispos; 2012 Sep; 33(6):304-15. PubMed ID: 22847220 [TBL] [Abstract][Full Text] [Related]
13. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer]. Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290 [TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522 [TBL] [Abstract][Full Text] [Related]
15. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. Dahan A; Amidon GL Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926 [TBL] [Abstract][Full Text] [Related]
16. HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition. Kis O; Sankaran-Walters S; Hoque MT; Walmsley SL; Dandekar S; Bendayan R Antimicrob Agents Chemother; 2016 May; 60(5):2771-81. PubMed ID: 26902756 [TBL] [Abstract][Full Text] [Related]
17. Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein. Lecoeur S; Videmann B; Mazallon M Toxicol Lett; 2006 Mar; 161(3):200-9. PubMed ID: 16221533 [TBL] [Abstract][Full Text] [Related]
18. Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer. Yuan J; Lv H; Peng B; Wang C; Yu Y; He Z Cancer Chemother Pharmacol; 2009 May; 63(6):1103-10. PubMed ID: 18820913 [TBL] [Abstract][Full Text] [Related]
19. ATP-binding cassette proteins BCRP, MRP1 and P-gp expression and localization in the human umbilical cord. Riches Z; Walia G; Berman JM; Wright TE; Collier AC Xenobiotica; 2016; 46(6):548-56. PubMed ID: 26407213 [TBL] [Abstract][Full Text] [Related]
20. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems. Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]